Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8774

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 01)

Chemical structure of venlafaxine hydrochloride showing the molecular arrangement including a methoxyphenyl group, cyclohexanol, and a dimethylaminoethyl side chain.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 02)

A pharmacokinetic chart showing fold change and 90% confidence intervals for venlafaxine and metabolite ODV in various special populations, including hepatic and renal impairments, CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents change relative to the reference value, with plotted points for Cmax and AUC values.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 03)

A statistical chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine when interacting with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis represents fold change relative to a reference value, with data points and error bars illustrating variability.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 04)

A forest plot displaying the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of various interacting drugs and analytes relative to a reference value. The chart includes data for multiple substances such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, desipramine, haloperidol, caffeine, toltubamide, and lithium, showing their respective fold changes on a horizontal axis starting from 0 to 3.*

FDA Label Image

Venlafaxine HCl Extended-release Capsules Usp 150mg (Eb320e98 85d0 421f 963d 825fb8e3c621 07)

Label for Venlafaxine HCl Extended-Release Capsules USP 150 mg by Preferred Pharmaceuticals Inc. The label includes dosage form and strength, manufacturer as Zydus Lifesciences Ltd., and space for lot number, batch, and expiration date. It features bilingual directions for use in English and Spanish, with a caution against unauthorized drug transfer. The capsule is described as orange and white, imprinted with ZA-37 150mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.